Galena Biopharma to Present at the 12th Annual Needham Healthcare Conference

Galena Biopharma to Present at the 12th Annual Needham Healthcare Conference

LAKE OSWEGO, Ore., April 24, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma
(Nasdaq:GALE), a biopharmaceutical company developing innovative, targeted
oncology treatments that address major unmet medical needs to advance cancer
care, today announced that Mark J. Ahn, Ph.D., President and Chief Executive
Officer, will present a corporate update at the 12^th Annual Needham
Healthcare Conference. The presentation will take place on Wednesday, May 1,
2013 at 1:40 p.m. ET at the Westin Grand Central Hotel in New York, NY.

The presentation will be webcast and available on the Investors section of the
Company's website at www.galenabiopharma.com.

About Galena Biopharma

Galena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based
biopharmaceutical company developing innovative, targeted oncology treatments
that address major unmet medical needs to advance cancer care. For more
information please visit us at www.galenabiopharma.com.

CONTACT: Madeline Hatton
         Toll free: +1 (855) 855-GALE (4253), ext. 109
         info@galenabiopharma.com
        
         Or
        
         Remy Bernarda
         +1 (503) 400-6995
         rbernarda@galenabiopharma.com

Galena Biopharma, Inc.